These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38849042)

  • 1. Corrigendum to "Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis" [Eur. J. Pharmacol. 779 (2016) 20-30 doi: 10.1016/j.ejphar.2016.02.067].
    Huang SS; Chen DZ; Wu H; Chen RC; Du SJ; Dong JJ; Liang G; Xu LM; Wang XD; Yang YP; Yu ZP; Feng WK; Chen YP
    Eur J Pharmacol; 2024 Aug; 977():176713. PubMed ID: 38849042
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis.
    Huang SS; Chen DZ; Wu H; Chen RC; Du SJ; Dong JJ; Liang G; Xu LM; Wang XD; Yang YP; Yu ZP; Feng WK; Chen YP
    Eur J Pharmacol; 2016 May; 779():22-30. PubMed ID: 26945822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.
    Pan Y; Wang Y; Cai L; Cai Y; Hu J; Yu C; Li J; Feng Z; Yang S; Li X; Liang G
    Br J Pharmacol; 2012 Jun; 166(3):1169-82. PubMed ID: 22242942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin analogue C66 attenuates obesity-induced renal injury by inhibiting chronic inflammation.
    Ye L; Hu X; Hu X; Yin S; Chen J; He H; Hong S; Yang B; Singh KK; Feng J; Wang Y; Luo W; Liang G
    Biomed Pharmacother; 2021 May; 137():111418. PubMed ID: 33761621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications.
    Mladenov M; Bogdanov J; Bogdanov B; Hadzi-Petrushev N; Kamkin A; Stojchevski R; Avtanski D
    Mol Med; 2022 Oct; 28(1):129. PubMed ID: 36316651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Concern.
    Listed NA
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):445. PubMed ID: 38305629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin analogue C66 attenuates obesity-induced myocardial injury by inhibiting JNK-mediated inflammation.
    Ye L; Chen X; Wang M; Jin L; Zhuang Z; Yang D; Guan X; Samorodov AV; Pavlov VN; Chattipakorn N; Feng J; Wang Y; Luo W; Liang G
    Biomed Pharmacother; 2021 Nov; 143():112121. PubMed ID: 34474346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of the novel curcumin analogue C66 in diabetic mice is dependent on JNK2 inactivation.
    Li C; Miao X; Lou Y; Lu Z; Adhikari BK; Wang Y; Liu Q; Sun J; Wang Y
    J Cell Mol Med; 2018 Dec; 22(12):6314-6326. PubMed ID: 30320490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Curcumin C66 That Protects Diabetes-Induced Aortic Damage Was Associated with Suppressing JNK2 and Upregulating Nrf2 Expression and Function.
    Li C; Miao X; Wang S; Adhikari BK; Wang X; Sun J; Liu Q; Tong Q; Wang Y
    Oxid Med Cell Longev; 2018; 2018():5783239. PubMed ID: 30622669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome" [Eur. J. Pharmacol. (2018), 836 34-43].
    Salaga M; Binienda A; Tichkule RB; Thakur GA; Makriyannis A; Storr M; Fichna J
    Eur J Pharmacol; 2019 Nov; 862():172656. PubMed ID: 31519354
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice" [Eur. J. Pharmacol. 666 (2011) 196-204].
    Li JM; Zhang X; Wang X; Xie YC; Kong LD
    Eur J Pharmacol; 2022 Feb; 916():174740. PubMed ID: 34996605
    [No Abstract]   [Full Text] [Related]  

  • 12. Curcumin analog C66 alleviates inflammatory colitis by inhibiting the activation of NF-κB.
    Hu C; Chen Y; Zhang L; Liu M; Yang J; Huang F; Wang Y; Huang L
    Inflammopharmacology; 2022 Dec; 30(6):2167-2179. PubMed ID: 36261684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of JNK by novel curcumin analog C66 prevents diabetic cardiomyopathy with a preservation of cardiac metallothionein expression.
    Wang Y; Zhou S; Sun W; McClung K; Pan Y; Liang G; Tan Y; Zhao Y; Liu Q; Sun J; Cai L
    Am J Physiol Endocrinol Metab; 2014 Jun; 306(11):E1239-47. PubMed ID: 24714399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathway" [Eur. J. Pharmacol. 791 (2016) 229-234].
    Haiyan F; Zhansheng H; Xingwei D; Qiuhong Z; Rongbin Z; Hongyang D
    Eur J Pharmacol; 2016 Dec; 792():78. PubMed ID: 27916228
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway" [Eur. J. Pharmacol. 873 (2020) 173007].
    Yuan H; Duan S; Guan T; Yuan X; Lin J; Hou S; Lai X; Huang S; Du X; Chen S
    Eur J Pharmacol; 2020 Aug; 880():173160. PubMed ID: 32460965
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel curcumin analog C66 prevents diabetic nephropathy via JNK pathway with the involvement of p300/CBP-mediated histone acetylation.
    Wang Y; Wang Y; Luo M; Wu H; Kong L; Xin Y; Cui W; Zhao Y; Wang J; Liang G; Miao L; Cai L
    Biochim Biophys Acta; 2015 Jan; 1852(1):34-46. PubMed ID: 25446993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin analogue C66 ameliorates mouse cardiac dysfunction and structural disorders after acute myocardial infarction via suppressing JNK activation.
    Hao H; Yuan T; Li Z; Zhang C; Liu J; Liang G; Feng L; Pan Y
    Eur J Pharmacol; 2023 May; 946():175629. PubMed ID: 36868294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy.
    Pan Y; Wang Y; Zhao Y; Peng K; Li W; Wang Y; Zhang J; Zhou S; Liu Q; Li X; Cai L; Liang G
    Diabetes; 2014 Oct; 63(10):3497-511. PubMed ID: 24848068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21.
    Wu H; Kong L; Tan Y; Epstein PN; Zeng J; Gu J; Liang G; Kong M; Chen X; Miao L; Cai L
    Diabetologia; 2016 Jul; 59(7):1558-1568. PubMed ID: 27115417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-100beta protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5 HT(1A)-receptor agonist, Bay x 3702.
    Ahlemeyer B; Beier H; Semkova I; Schaper C; Krieglstein J
    Brain Res; 2000 Mar; 858(1):121-8. PubMed ID: 10700604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.